Similar articles

• Tl-201 SPECT and F-18 FDG PET for assessment of glioma recurrence versus radiation necrosis.

  Siepmann DB, Siegel A, Lewis PJ. Siepmann DB, et al. Clin Nucl Med. 2005 Mar;30(3):199-200. doi: 10.1097/00003072-200503000-00015. Clin Nucl Med. 2005. PMID: 15722830 No abstract available.
• Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

  Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM. Patronas NJ, et al. Radiology. 1982 Sep;144(4):885-9. doi: 10.1148/radiology.144.4.6981123. Radiology. 1982. PMID: 6981123
• Determination of brain tumor recurrence using ¹¹ C-methionine positron emission tomography after radiotherapy.

  Yamaguchi S, Hirata K, Okamoto M, Shimosegawa E, Hatazawa J, Hirayama R, Kagawa N, Kishima H, Oriuchi N, Fujii M, Kobayashi K, Kobayashi H, Terasaka S, Nishijima KI, Kuge Y, Ito YM, Nishihara H, Tamaki N, Shiga T. Yamaguchi S, et al. Cancer Sci. 2021 Oct;112(10):4246-4256. doi: 10.1111/cas.15001. Epub 2021 Aug 13. Cancer Sci. 2021. PMID: 34061417 Free PMC article.
• [11C-methionine positron emission tomography in brain tumor].

  Kawai N, Kagawa M, Hatakeyama T, Tamiya T, Noshiyama Y, Yamamoto Y, Miki A, Ichikawa T. Kawai N, et al. No Shinkei Geka. 2008 Oct;36(10):847-59. No Shinkei Geka. 2008. PMID: 18975560 Review. Japanese. No abstract available.
• Glioblastoma multiforme imaging: the role of nuclear medicine.

  Alexiou GA, Tsiouris S, Voulgaris S, Kyritsis AP, Fotopoulos AD. Alexiou GA, et al. Curr Radiopharm. 2012 Oct;5(4):308-13. doi: 10.2174/1874471011205040308. Curr Radiopharm. 2012. PMID: 22642425 Review.